Longeveron is a clinical-stage biotechnology company developing cellular therapies for ageing-related and life-threatening conditions. Its lead product aims to improve outcomes in patients with frailty and chronic conditions.
Longeveron is a clinical-stage biotechnology company developing cellular therapies for ageing-related and life-threatening conditions. Its lead product aims to improve outcomes in patients with frailty and chronic conditions.